Literature DB >> 17639871

Contralateral conjugate eye deviation during deep brain stimulation of the subthalamic nucleus.

Donald C Shields1, Alessandra Gorgulho, Eric Behnke, Dennis Malkasian, Antonio A F DeSalles.   

Abstract

OBJECT: Deep brain stimulation of the subthalamic nucleus (STN) in patients with Parkinson disease is often very effective for treatment of debilitating motor symptoms. Nevertheless, the small size of the STN and its proximity to axonal projections results in multiple side effects during high-frequency stimulation. Contralateral eye deviation is produced in a small percentage of patients, but the precise mechanism of this side effect is at present poorly understood.
METHODS: Contralateral eye deviation was produced by high-frequency stimulation of 22 contact sites in nine patients undergoing deep brain stimulation of the STN. The precise locations of these contacts were calculated and compiled in order to locate the stimulated structure responsible for eye deviation.
RESULTS: The mean x, y, and z coordinates associated with contralateral eye deviation were found to be 11.57, 2.03, and 3.83 mm lateral, posterior, and inferior to the anterior commissure-posterior commissure midpoint, respectively. The point described by these coordinates is located within the lateral anterosuperior border of the STN.
CONCLUSIONS: Given that stimulation of frontal eye field cortical regions produces similar contralateral conjugate eye deviation, these results are best explained by electrical current spread to nearby frontal eye field axons coursing lateral to the STN within the internal capsule. Thus, placement of the implanted electrode in a more medial, posterior, and inferior position may bring resolution of these symptoms by reducing the amount of current spread to internal capsule ax-

Entities:  

Mesh:

Year:  2007        PMID: 17639871     DOI: 10.3171/JNS-07/07/0037

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  Diplopia associated with loop routing in deep brain stimulation: illustrative case.

Authors:  Yasushi Miyagi; Eiichirou Urasaki
Journal:  J Neurosurg Case Lessons       Date:  2021-01-04

2.  Diffusion tensor imaging (DTI) and colored fractional anisotropy (FA) mapping of the subthalamic nucleus (STN) and the globus pallidus interna (GPi).

Authors:  Mark Sedrak; Alessandra Gorgulho; Ausaf Bari; Eric Behnke; Andrew Frew; Inga Gevorkyan; Nader Pouratian; Antonio DeSalles
Journal:  Acta Neurochir (Wien)       Date:  2010-10-03       Impact factor: 2.216

3.  Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy.

Authors:  Philip A Starr; Alastair J Martin; Jill L Ostrem; Pekka Talke; Nadja Levesque; Paul S Larson
Journal:  J Neurosurg       Date:  2010-03       Impact factor: 5.115

4.  Clinical outcomes of PD patients having bilateral STN DBS using high-field interventional MR-imaging for lead placement.

Authors:  Jill L Ostrem; Nicholas B Galifianakis; Leslie C Markun; Jamie K Grace; Alastair J Martin; Philip A Starr; Paul S Larson
Journal:  Clin Neurol Neurosurg       Date:  2012-09-01       Impact factor: 1.876

Review 5.  Vergence and Strabismus in Neurodegenerative Disorders.

Authors:  Sarah L Kang; Aasef G Shaikh; Fatema F Ghasia
Journal:  Front Neurol       Date:  2018-05-16       Impact factor: 4.003

6.  An unusual presentation of convergence insufficiency in a patient with Parkinson's disease stimulated by deep brain stimulation.

Authors:  Rayan Abou Khzam; Nahia Dib El Jalbout; Roland Seif; Ama Sadaka
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-16

7.  Basal ganglia neuronal activity during scanning eye movements in Parkinson's disease.

Authors:  Tomáš Sieger; Cecilia Bonnet; Tereza Serranová; Jiří Wild; Daniel Novák; Filip Růžička; Dušan Urgošík; Evžen Růžička; Bertrand Gaymard; Robert Jech
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.